We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+14.43%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$166M
AUM Growth
-$10.9M
Cap. Flow
-$8.15M
Cap. Flow %
-4.9%
Top 10 Hldgs %
65.79%
Holding
63
New
18
Increased
12
Reduced
1
Closed
32

Top Buys

Rank Stock Value
1
GYRE icon
Gyre Therapeutics
GYRE
+$23.6M
2
SNY icon
Sanofi
SNY
+$17M
3
BIIB icon
Biogen
BIIB
+$9.9M
4
MRK icon
Merck
MRK
+$6.5M
5
KURA icon
Kura Oncology
KURA
+$5.17M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$11.6M
2
QTNT
Quotient Limited Ordinary Shares
QTNT
+$7.06M
3
AET
Aetna Inc
AET
+$4.75M
4
EBS icon
Emergent Biosolutions
EBS
+$4.25M
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$3.43M

Sector Composition

Rank Sector Weight
1 Healthcare 85.74%
2 Financials 3.21%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYOV
51
DELISTED
Myovant Sciences Ltd.
MYOV
– –
-73,054
Closed -$923K
QTNT
52
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-35,653
Closed -$7.06M
CCXI
53
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-83,428
Closed -$496K
NTUS
54
PUT
DELISTED
Natus Medical Inc
NTUS
– –
-53,000
Closed -$2.02M
VCRA
55
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-55,454
Closed -$1.68M
ODT
56
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
– –
-50,000
Closed -$1.25M
ADMS
57
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-35,000
Closed -$1.19M
GWPH
58
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-19,000
Closed -$2.51M
PGNX
59
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-83,523
Closed -$497K
FOMX
60
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-131,200
Closed -$789K
OASM
61
DELISTED
Oasmia Pharmaceutical AB
OASM
– –
-203,170
Closed -$179K
STDY
62
DELISTED
SteadyMed Ltd
STDY
– –
-54,950
Closed -$203K
AAAP
63
DELISTED
Advanced Accelerator Applications S.A.
AAAP
– –
-32,736
Closed -$2.67M
1 2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Sio Capital Management held 63 positions worth $166M, down 6.1% from $177M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sio Capital Management withdrew a net $8.15M in Q1 2018, closing 32 positions and reducing 1 holding. Its most notable exit was GSK, an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 49% a quarter earlier, followed by Financials and Technology.

Against the trend, Sio Capital Management opened a new position in Sanofi worth $16.4M.

  • Sio Capital Management's largest Q1 2018 buy was Sanofi: 408,621 shares worth $16.4M.
  • Sio Capital Management added most to Gyre Therapeutics in Q1 2018, an estimated $23.6M increase.
  • Sio Capital Management's biggest Q1 2018 reduction was Aetna Inc, cutting an estimated $4.75M.
  • Sio Capital Management fully exited GSK in Q1 2018, selling an estimated $11.6M.
  • Sio Capital Management's ten largest holdings make up 66% of its $166M portfolio in Q1 2018.
  • Sio Capital Management opened 18 new positions and closed 32 in Q1 2018.
  • Sio Capital Management's portfolio value fell 6.1% quarter-over-quarter to $166M.

Based on Sio Capital Management's 13F filing for Q1 2018, filed 15 May 2018.